Opening Asia for Russia

China has published a list of 4 vaccines allowed for export

23.06.2021 95 просмотров

On June 22, China added four COVID-19 vaccines that had received conditional approval for the domestic market to the list of vaccine products allowed for export.

According to the Chinese Ministry of Commerce website, these four vaccines are manufactured by Beijing Institute of Biological Products Co, Ltd., Sinovac Life Sciences Co, Ltd., CanSino Biologics Inc., respectively. and Wuhan Institute of Biological Products Co., Ltd.

Of these, two drugs manufactured by Beijing Institute of Biological Products Co., Ltd. and Sinovac Life Sciences Co., Ltd. are already listed by the World Health Organization (WHO) for emergency use.

4 vaccines 3.jpg

The listed vaccines were used for mass vaccination in China and approved for use in about 100 countries, said Ministry spokesman Li Xingqian.

"In order to ensure the quality and safety of vaccine products and improve trade efficiency, we support the listed Chinese vaccine manufacturers to independently export, focus on increasing the supply of products, stabilized market expectations and made vaccines accessible and affordable to all countries, especially developing countries," he said.

4 vaccines 4.jpg

"We will continue to support domestic vaccine manufacturers to strengthen cooperation with COVAX, as well as joint research, development and joint production of vaccines with other countries," stated Li Xingqian. b>
A representative of the Ministry of Commerce of the People's Republic of China added that the list will be adjusted according to the approval and listing process of the National Medical Products Administration.

According to him, the agency will cooperate with relevant parties to assist foreign countries in the procurement of vaccines from China, will take concrete measures to help make vaccines a global public good and help build a World Community with a shared health destiny.

4 vaccines 1.jpg

COVAX is an international initiative aimed on ensuring equal access to vaccines.

Новости партнёров